Long-Term Benefits of Thyroidectomy for Graves’ Disease | oneGRAVESvoice
Global Search
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Scientific Articles

Long-Term Benefits of Thyroidectomy for Graves’ Disease

key information

source: Clinical Thyroidology®

year: 2021

authors: Lilah F. Morris-Wiseman

summary/abstract:

Graves’ disease, the most common cause of hyperthyroidism, has typically been treated sequentially with antithyroid drugs (ATDs), then radioactive iodine (RAI) for patients for whom initial medical management fails. Surgery is traditionally reserved for patients with contraindications to radiation or ophthalmopathy or a need for rapid control of hyperthyroidism. Only approximately 6% of patients in the United States undergo thyroidectomy for initial management of Graves’ disease. This study aimed to compare, by first-line treatment, long-term outcomes of patients with Graves’ disease (including all-cause mortality, cardiovascular disease, atrial fibrillation, neuropsychiatric symptoms, diabetes, and hypertension), 10-year health care costs, and risk of relapse.

organization: University of Arizona School of Medicine, USA

DOI: 10.1089/ct.2021;33.354-356

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Powered by

Brought to you by

Supported through an independent
educational grant by

© 2022 rareLife solutions Inc.